To determine if HDAC2 could potentially serve as an early biomarker of colorectal cancer, we also analyzed HDAC2 expression in the azoxymethane (AOM)-injected rat model that mimics early stages of the adenoma-carcinoma sequence of human CRC. This evidence concerns the gene HDAC2 and colorectal cancer.